Literature DB >> 31112663

Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?

Anna Tølbøll Svendsen1,2, Peter Bytzer1,2, Anne Line Engsbro3.   

Abstract

Objective: Acute gastroenteritis (AGE) is a risk factor for post-infectious irritable bowel syndrome (PI-IBS). This systematic review evaluates the prevalence and risk-factors of PI-IBS after AGE by specific pathogens. Materials and methods: Medline (1966-2019) and Embase (1974-2019) were searched for studies evaluating PI-IBS minimum 3 months after AGE with Campylobacter spp., Salmonella spp., Shigella spp., Escherischia coli, Clostridium difficile, norovirus, rotavirus, Cryptosporidium spp. or Giardia intestinalis using validated criteria for IBS. Pooled prevalence (PP), odds ratios (OR) and risk factors were determined for single pathogens, groups of bacteria, viruses and parasites, and overall for AGE caused by any pathogen. Random-effect models were used for meta-analyses.
Results: A total of 34 articles were included. PP of PI-IBS after Campylobacter spp. was 12% (confidence interval 95% [CI]: 10-15%), Salmonellosis 12% (CI: 9-15%), Shigellosis 11% (CI: 8-15%), C. difficile 14% (CI: 4-29%) and E. coli spp. 12% (CI: 5-20%). OR of PI-IBS after salmonellosis was 5.5 (CI: 2.3-12.8) and after shigellosis 13.8 (CI: 4.2-45.4). Bacterial AGE overall showed OR 5.8 (CI: 4.0-8.3) and AGE caused by any pathogen OR 4.9 (CI: 3.9-6.1). Few studies exist on viral and parasitic gastroenteritis. Conclusions: Current literature show similar risks for bacterial pathogens. Studies are limited for viral and parasitic pathogens. The evaluated risk-factors for PI-IBS varied among the included studies and the existing evidence is insufficient to identify pathogen-specific risk factors.

Entities:  

Keywords:  Functional-disorders; GI-infections; gastrointestinal diseases; irritable bowel syndrome; meta-analysis

Mesh:

Year:  2019        PMID: 31112663     DOI: 10.1080/00365521.2019.1607897

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

Review 1.  Epidemiology, Clinical Features, and Unusual Complications of Norovirus Infection in Taiwan: What We Know after Rotavirus Vaccines.

Authors:  Meng-Che Lu; Sheng-Chieh Lin; Yi-Hsiang Hsu; Shih-Yen Chen
Journal:  Pathogens       Date:  2022-04-09

Review 2.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 3.  Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease.

Authors:  Valeria Dipasquale; Stefano Passanisi; Ugo Cucinotta; Antonio Cascio; Claudio Romano
Journal:  Ital J Pediatr       Date:  2021-03-24       Impact factor: 2.638

4.  Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.

Authors:  Srishti Saha; Kanika Sehgal; Sumitabh Singh; Madhusudan Grover; Darrell Pardi; Sahil Khanna
Journal:  J Clin Gastroenterol       Date:  2022-02-01       Impact factor: 3.174

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.